Review Note
Last Update: 02/29/2024 03:20 AM
Current Deck: Ankilling It::EGGS::Week 3::04 Hepatitis and Chronic Liver Disease
Published
Fields:
Text
Second generation NS3/NS4A protease inhibitors and NS5A inhibitors are under clinical investigation to develop HCV treatment regimens that do not require {{c1::interferon/ribavirin}} administration
Extra

Lecture Notes
Missed Questions
Pathoma
Boards and Beyond
First Aid


Sketchy
Sketchy Pharmacology: GI (Hepatitis)


Pixorize
Physeo
Additional Resources
One by one
Bootcamp
Picmonic
Sketchy 2
Sketchy Extra
Tags:
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: